Literature DB >> 1437144

p53 mutations in Raji cells: characterization and localization relative to other Burkitt's lymphomas.

A Duthu1, B Debuire, J Romano, J C Ehrhart, M Fiscella, E May, E Appella, P May.   

Abstract

The nuclear phosphoprotein p53 is an important regulator of cell proliferation in normal cells. Interestingly, the gene encoding p53 has usually undergone mutations in a wide range of tumor types. Recent studies of the p53 gene in Burkitt's lymphomas have demonstrated that mutations are extremely common, and in fact it is rare that both alleles of the p53 gene in these tumors are not inactivated by mutation or deletion. We present here genetic data regarding the status of the p53 gene in the Burkitt lymphoma cell line, Raji. As is typical for this type of tumor, both alleles have undergone point mutations. Further, statistical analysis of available data from a large number of Burkitt's lymphomas indicates an apparent tumor-specific distribution of p53 mutations. The possibility that specific mutations of the p53 gene may be important for different tumor types is discussed.

Entities:  

Mesh:

Year:  1992        PMID: 1437144

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  13 in total

1.  Inhibition of Aurora A Kinase in Combination with Chemotherapy Induces Synthetic Lethality and Overcomes Chemoresistance in Myc-Overexpressing Lymphoma.

Authors:  Steven I Park; Carolina P Lin; Natalie Ren; Steven P Angus; Dirk P Dittmer; Michael Foote; Trevor Parton; Aadra P Bhatt; Yuri D Fedoriw; Daniel P Roth; Marissa L Cann; Gary L Johnson; Blossom Damania
Journal:  Target Oncol       Date:  2019-10       Impact factor: 4.493

2.  Targeting protein neddylation with an NEDD8-activating enzyme inhibitor MLN4924 induced apoptosis or senescence in human lymphoma cells.

Authors:  Yanchun Wang; Zhongguang Luo; Yongfu Pan; Weige Wang; Xiaoyan Zhou; Lak Shin Jeong; Yiwei Chu; Jie Liu; Lijun Jia
Journal:  Cancer Biol Ther       Date:  2015       Impact factor: 4.742

3.  Transcriptional consequences of topoisomerase inhibition.

Authors:  I Collins; A Weber; D Levens
Journal:  Mol Cell Biol       Date:  2001-12       Impact factor: 4.272

4.  Low-pH-induced apoptosis: role of endoplasmic reticulum stress-induced calcium permeability and mitochondria-dependent signaling.

Authors:  Vishal Sharma; Ramandeep Kaur; Archana Bhatnagar; Jagdeep Kaur
Journal:  Cell Stress Chaperones       Date:  2015-04-01       Impact factor: 3.667

5.  Mutant p53 exhibits trivial effects on mitochondrial functions which can be reactivated by ellipticine in lymphoma cells.

Authors:  Fei Wang; Jianfeng Liu; Delira Robbins; Kerri Morris; Amos Sit; Yong-Yu Liu; Yunfeng Zhao
Journal:  Apoptosis       Date:  2011-03       Impact factor: 4.677

6.  Alterations of the p53 gene in Epstein-Barr virus-associated immunodeficiency-related lymphomas.

Authors:  R H Edwards; N Raab-Traub
Journal:  J Virol       Date:  1994-03       Impact factor: 5.103

7.  Interferon-inducible protein IFIXalpha1 functions as a negative regulator of HDM2.

Authors:  Yi Ding; Jin-Fong Lee; Hua Lu; Mong-Hong Lee; Duen-Hwa Yan
Journal:  Mol Cell Biol       Date:  2006-03       Impact factor: 4.272

8.  Sulfonoquinovosyl diacylglyceride selectively targets acute lymphoblastic leukemia cells and exerts potent anti-leukemic effects in vivo.

Authors:  Chetan Kumar Jain; Bhola Shankar Pradhan; Sukdeb Banerjee; Nirup Bikash Mondal; Subeer S Majumder; Madhumita Bhattacharyya; Saikat Chakrabarti; Susanta Roychoudhury; Hemanta Kumar Majumder
Journal:  Sci Rep       Date:  2015-07-20       Impact factor: 4.379

9.  DNA damage in human B cells can induce apoptosis, proceeding from G1/S when p53 is transactivation competent and G2/M when it is transactivation defective.

Authors:  M J Allday; G J Inman; D H Crawford; P J Farrell
Journal:  EMBO J       Date:  1995-10-16       Impact factor: 11.598

10.  Epstein-Barr virus efficiently immortalizes human B cells without neutralizing the function of p53.

Authors:  M J Allday; A Sinclair; G Parker; D H Crawford; P J Farrell
Journal:  EMBO J       Date:  1995-04-03       Impact factor: 11.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.